Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oden

Showing results (411-420 of 589) with videos related to

Pageof 59
Sort By:
Ophthalmology|October 8, 2010
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10Ingrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
Nature Materials|August 15, 2006
A new view of the onset of plasticity during the nanoindentation of aluminiumAndrew M Minor, S A Syed Asif, Zhiwei Shan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 15, 2012
Inflammatory bowel disease and the risk of fracture after controlling for FRAXLaura E Targownik, Charles N Bernstein, Zoann Nugent, et al.
JAMA Ophthalmology|February 25, 2018
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
Ophthalmology|January 27, 2009
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
JAMA Ophthalmology|December 28, 2018
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 StudyMichael S Ip, Neal L Oden, Ingrid U Scott, et al.
JAMA Ophthalmology|October 28, 2021
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical TrialAhmad A Aref, Ingrid U Scott, Paul C VanVeldhuisen, et al.
Ophthalmology|April 7, 2009
SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion typeIngrid U Scott, Barbara A Blodi, Michael S Ip, et al.
BMC Palliative Care|August 15, 2013
Novel open-source electronic medical records system for palliative care in low-resource settingsKamal G Shah, Tara Lyn Slough, Ping Teresa Yeh, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1985
Pharmacokinetics of Sch 34343 in rats and dogsC Lin, D Loebenberg, M Chung, et al.
Pageof 59

Showing results (411-420 of 589) with videos related to

Sort By:
Pageof 59
Ophthalmology|October 8, 2010
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10Ingrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
Nature Materials|August 15, 2006
A new view of the onset of plasticity during the nanoindentation of aluminiumAndrew M Minor, S A Syed Asif, Zhiwei Shan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 15, 2012
Inflammatory bowel disease and the risk of fracture after controlling for FRAXLaura E Targownik, Charles N Bernstein, Zoann Nugent, et al.
JAMA Ophthalmology|February 25, 2018
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
Ophthalmology|January 27, 2009
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
JAMA Ophthalmology|December 28, 2018
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 StudyMichael S Ip, Neal L Oden, Ingrid U Scott, et al.
JAMA Ophthalmology|October 28, 2021
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical TrialAhmad A Aref, Ingrid U Scott, Paul C VanVeldhuisen, et al.
Ophthalmology|April 7, 2009
SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion typeIngrid U Scott, Barbara A Blodi, Michael S Ip, et al.
BMC Palliative Care|August 15, 2013
Novel open-source electronic medical records system for palliative care in low-resource settingsKamal G Shah, Tara Lyn Slough, Ping Teresa Yeh, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1985
Pharmacokinetics of Sch 34343 in rats and dogsC Lin, D Loebenberg, M Chung, et al.
Pageof 59